Home » News » Currently Reading:

News 3/19/25

March 18, 2025 News 1 Comment

Top News

image

Veradigm files its long-overdue 2022 10-K, which also contains certain restated financial statements for periods in fiscal year 2022, 2021 and 2020.

Total revenue rose slightly in 2022, but EPS from continuing operations plunged from $0.92 to –$0.18, with an $86 million loss.

Nasdaq delisted MDRX in February after the company failed to file its 2022 report and multiple quarterly statements. Veradigm attributed the issue to a software error that overstated financials over six quarters.

MDRX shares, which now trade on the OTC market, have fallen 40% in the past year. The company hopes to regain Nasdaq listing status.

Veradigm spent eight months through January 2025 seeking a buyer, but received no offers from 30 interested parties.


HIStalk Executive Watercooler

image

I’m bringing back a simple way for health system technology executives to share their candid insights anonymously, effortlessly, and with influence. See this example of the result back when I called it the HIStalk Advisory Panel.

Once a month, I’ll email you one quick question. Just hit reply with your thoughts. I’ll compile responses (stripping out anything identifiable to maintain your anonymity) and write them up for HIStalk. You will be influencing industry conversations with minimal effort.

I’m looking for executives from health systems, ACOs, and hospital-owned medical practices; CMIOs, CNIOs, and clinical informaticists; health system IT leaders; and digital health executives. Provider-side only, please. Thank you for signing up to be part of the HIStalk Executive Watercooler.


Sponsored Events and Resources

Live Webinar: March 20 (Thursday) noon ET. “Enhancing Patient Experience: Digital Accessibility Legal Requirements in Healthcare.” Sponsor: TPGi. Presenters: Mark Miller, director of sales, TPGi; David Sloan, PhD, MSc, chief accessibility officer, TPGi; Kristina Launey, JD, labor and employment litigation and counseling partner, Seyfarth Shaw LLP. For patients with disabilities, inaccessible technology can mean the difference between timely, effective care and unmet healthcare needs. This could include accessible patient portals, telehealth services, and payment platforms. Despite a new presidential administration, requirements for Section 1557 of the Affordable Care Act (ACA) have not changed. While enforcement may unclear moving forward, healthcare organizations still have an obligation to their patients for digital accessibility. In our webinar session, TPGi’s accessibility experts and Seyfarth Shaw’s legal professionals will help you understand ACA Section 1557 requirements, its future under the Trump administration, and offer strategies to help you create inclusive experiences.

Live Webinar: March 27 (Thursday) noon ET. “How to Improve Clinical Workflows with AI Chart Summaries and Risk Predictions.” Sponsor: Health Data Analytics Institute. Presenters: Scott Cullen, MD, senior advisor, Health Data Analytics Institute; David Clain, chief product officer, Health Data Analytics Institute. Learn how the EHR-embedded HDAIAssist tool is transforming the ability of clinicians to pull insights out the mountains of data that have accumulated in the EHR, quickly, accurately, and cost-effectively. HDAlAssist, which is part of HealthVision, the intelligent health management system, combines AI chart summaries and granular risk predictions to quickly inform care planning decisions, especially for the most complex, high-risk patients.

Contact Lorre to have your resource listed.


Acquisitions, Funding, Business, and Stock

image

AI-powered RCM vendor Infinx marks its second acquisition of the year with the purchase of Glidian, a prior authorization automation company based in California. It acquired pathology billing and RCM business MedReceivables Advisor earlier this year.


People

image

Nordic appoints Steve Eckert, MBA (Cook Children’s Health Care System) chief growth officer.

image

Siemens Healthineers names John Kowal president and head of the Americas. He was formerly president of the Americas at Varian Medical Systems, which Siemens acquired in 2021.

image

Loyal names Nanette Oddo (Truveris) CEO.

image

Jeff Evans (CAE Healthcare) joins Qventus as chief commercial officer.

image

J. Michael Kramer, MD, MBA (Health Value Leadership) joins Cone Health (NC) as CMIO.


Announcements and Implementations

EHR vendor Canvas Medical announces an open source AI copilot and ambient documentation system.


Government and Politics

NHS England informs 5,000 patients of an administrative error that blocked them from receiving routine screening reminders. The decades-long issue, initially identified on a small scale last year, stemmed from GP practices failing to fully complete patient registrations, preventing automatic transfer of data to screening reminder systems.


Sponsor Updates

  • Altera Digital Health publishes a new client story titled “Psychology service digitised and integrated into trust-wide EPR at Liverpool Heart and Chest Hospital.”
  • AvaSure will exhibit at AONL March 30-April 2 in Boston.
  • Capital Rx releases a new episode of “The Astonishing Healthcare Podcast” titled “Building Judi, the Healthcare Infrastructure of the Future, with Liya Lomsadze.”
  • Censinet releases a new case study titled “Enhancing Rural Healthcare Cybersecurity and Risk Management at Faith Regional.”
  • Clearwater publishes a first-of-its-kind report examining the cybersecurity performance of private equity-backed portfolio companies in healthcare.
  • DrFirst announces its products have earned HITRUST i1 certification for information security.
  • CliniComp wins a Platinum Pinnacle Award for its role as a Trailblazer in Healthcare Technology.

Blog Posts


Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Follow on X, Bluesky, and LinkedIn.
Contact us.



HIStalk Featured Sponsors

     

Currently there is "1 comment" on this Article:

  1. The MDRX restatement is a two year journey that doesn’t appear to be done yet. While the 2020-22 years were restated, their 2023-24 results appear to remain unaudited, I doubt that until they are audited MDRX will be delisted. MDRX is currently at $5.25 so the market isn’t really seeing anything in the restatement. It was at $15ish for the last 15 years with a peak of $22 in 2022.

    With the recent layoffs it is doubtful they will grow the business, especially as many of their products are based on EHRs that are transitioning to non-supported EHRs (Touchworks to Epic).

    While it is a milestone, it is a milestone that should never have happened.







Text Ads


RECENT COMMENTS

  1. The MDRX restatement is a two year journey that doesn't appear to be done yet. While the 2020-22 years were…

  2. RE: What ways have you recently used to reduce the time you spend on unproductive meetings? I've been using some…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.